World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
70
Citations
17035
World Ranking
7024
National Ranking
180

Ron H.N. van Schaik publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Ron H.N. van Schaik sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 272 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Ron H.N. van Schaik D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Ron H.N. van Schaik sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 70 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Ron H.N. van Schaik is affiliated with Erasmus University Rotterdam in the Netherlands. Their research primarily spans the field of Medicine, with a focus on subfields such as Oncology, Pharmacology, Molecular Biology, Pediatrics, Perinatology and Child Health, and Cardiology and Cardiovascular Medicine.

Their main topics of study include Pharmacogenetics and Drug Metabolism, Pharmaceutical Studies and Practices, Cancer Therapeutics and Mechanisms, Lung Cancer Treatments and Mutations, Pharmacological Effects and Toxicity Studies, Renal Transplantation Outcomes and Treatments, and Colorectal Cancer Treatments and Studies.

Ron H.N. van Schaik has contributed to several journals frequently, including:

  • European Journal of Human Genetics
  • Clinical Pharmacology & Therapeutics
  • Annals of Oncology
  • Journal of Molecular Diagnostics
  • Clinical Chemistry and Laboratory Medicine (CCLM)

Selected recent papers of Ron H.N. van Schaik include:

  • Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology, 2021, Therapeutic Drug Monitoring
  • Recommendations for Clinical CYP2D6 Genotyping Allele Selection, 2021, Journal of Molecular Diagnostics
  • Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics, 2023, European Journal of Human Genetics
  • Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs, 2021, European Journal of Human Genetics
  • Risperidone plasma concentrations are associated with side effects and effectiveness in children and adolescents with autism spectrum disorder, 2020, British Journal of Clinical Pharmacology

Frequent co-authors collaborating with Ron H.N. van Schaik include:

  • Ron H.J. Mathijssen
  • Henk-Jan Guchelaar
  • Jesse J. Swen
  • Mirjam de With
  • Esther Oomen-de Hoop

Best Publications

  • Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

    Fritz H Schröder;Jonas Hugosson;Monique J Roobol;Teuvo L J Tammela

  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch

  • Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR‐1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

    Dennis A. Hesselink;Ron H. N. van Schaik;Ilse P. van der Heiden;Marloes van der Werf

  • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

    K.A. Birdwell;B. Decker;J.M. Barbarino;J.F. Peterson

  • A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

    William J. Catalona;Alan W. Partin;Martin G. Sanda;John T. Wei

  • Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy : Second Consensus Report

    Mercè Brunet;Teun Van Gelder;Anders Åsberg;Vincent Haufroid;Vincent Haufroid

  • CYP3A5 variant allele frequencies in Dutch Caucasians.

    Ron H.N. van Schaik;Ilse P. van der Heiden;John N. van den Anker;John N. van den Anker;John N. van den Anker;Jan Lindemans

  • Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

    David V. Conti;Burcu F. Darst;Lilit C. Moss;Edward J. Saunders

  • Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics

    Femke M. de Man;Andrew K. L. Goey;Ron H. N. van Schaik;Ron H. J. Mathijssen

  • DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.

    Linda M. Henricks;Carin A.T.C. Lunenburg;Femke M. de Man;Didier Meulendijks

  • Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study.

    Matthijs L. Becker;Loes E. Visser;Ron H.N. van Schaik;Albert Hofman

  • Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection

    Flip H. Jansen;Ron H.N. van Schaik;Joep Kurstjens;Wolfgang Horninger

  • The prostate health index selectively identifies clinically significant prostate cancer

    Stacy Loeb;Martin G. Sanda;Dennis L. Broyles;Sanghyuk S. Shin

  • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.

    Matthew P. Goetz;Katrin Sangkuhl;Henk Jan Guchelaar;Matthias Schwab

  • A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients

    Laure Elens;Rachida Bouamar;Dennis A. Hesselink;Vincent Haufroid

  • Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: The effect of gender, race, and CYP2B6 polymorphism

    David Burger;Ilse van der Heiden;Charles la Porte;Marchina van der Ende

  • The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients

    Marzia Del Re;Elisa Biasco;Stefania Crucitta;Lisa Derosa

  • The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation

    Dennis A. Hesselink;Rachida Bouamar;Laure Elens;Ron H. N. Van Schaik

  • Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes

    Dennis A. Hesselink;Teun van Gelder;Ron H. N. van Schaik;Aggie H. M. M. Balk

  • CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy.

    Laure Elens;Teun van Gelder;Dennis A Hesselink;Vincent Haufroid;Vincent Haufroid

Frequent Co-Authors

Teun van Gelder
Teun van Gelder Leiden University Medical Center
Ron H.J. Mathijssen
Ron H.J. Mathijssen Erasmus University Rotterdam
Albert Hofman
Albert Hofman Harvard University
Bruno H. Stricker
Bruno H. Stricker Erasmus University Rotterdam
George P. Patrinos
George P. Patrinos University of Patras
Chris H. Bangma
Chris H. Bangma Erasmus University Rotterdam
David E. Neal
David E. Neal University of Cambridge
Henk-Jan Guchelaar
Henk-Jan Guchelaar Leiden University Medical Center
André G. Uitterlinden
André G. Uitterlinden Erasmus University Rotterdam
Alex Sparreboom
Alex Sparreboom The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens doors to a variety of rewarding healthcare and science careers. Many students explore specialized allied health fields that blend biology knowledge with hands-on clinical skills. For example, those interested in diagnostic technology can consider ultrasound tech programs online to prepare for a career in medical imaging.

Affordability is an important factor for many. If cost is a key concern, the cheapest radiology tech programs offer pathways to entry-level roles in medical technology and radiography without the heavy financial burden.

Those looking to integrate biology, health, and nutrition can pursue dietetics masters programs, leading to roles as registered dietitians and nutritionists. Additionally, for rapid entry into the healthcare workforce, students may choose medical assistant programs that also offer financial aid options.

These related online degree pathways make the most of a strong foundation in Biology and Biochemistry, and help graduates access diverse, in-demand career opportunities in health and science.

Best Scientists Citing Ron H.N. van Schaik

Trending Scientists